Works matching IS 10031057 AND DT 2021 AND VI 30 AND IP 9

Results: 12

The group of Professor Demin Zhou has made important progress in cytokine drugs long-acting targeting regulatory T cells for the treatment of autoimmune diseases.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 783, doi. 10.1002/anie.202108961
Publication type:: Article

The group of Professor Jing Wang used APEX2-based proximity labeling of atox1 identifies CRIP2 as a nuclear copper-binding protein that regulated autophagy activation.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 781, doi. 10.1002/anie.202108961
Publication type:: Article

Professor Ning Jiao awarded the third "SCIENCE XPLORER AWARD".

Published in:: Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 780, doi. 10.1021/acscatal.1c03064
Publication type:: Article

Cyclic peptide molecular biosynthesis-the group of Professor Ming Ma discovered the first catalytic isomerization/cyclic bifunctional thioesterase and analyzed its crystal structure.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 778, doi. 10.1021/acscatal.1c03064
Publication type:: Article

Study on the factors of knowledge and willingness of online prescription drug purchases in Shanghai residents.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 773, doi. 10.5246/jcps.2021.09.065

By:

Weijie Yan;
Lingxi Li;
Yanran Li;
Jie Min;
Zhixuan Zhang;
Yuliang Zhou;
Jiaoling Huang;
Li Zhang

Publication type:

Article

Association between CYP3A4 gene polymorphisms and clopidogrel response in patients with cardio-cerebrovascular diseases: a systematic review and Meta-analysis.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 762, doi. 10.5246/jcps.2021.09.064

By:

Sibei Qin;
Tong Jia;
Yu Fu;
Junlei Li;
Xinyi Zhang;
Chunsu Zhu;
Guangkai Liang;
Xiaoyan Nie;
Luwen Shi;
Yimin Cui

Publication type:

Article

Dropout reasons and associated factors with active dropout in Chinese healthy participants of bioequivalence studies.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 754, doi. 10.5246/jcps.2021.09.063

By:

Hengyi Yu;
Yinian Fang;
Kaifu Wang;
Qian Chen;
Aihua Du;
Xiuhua Ren;
Dong Liu

Publication type:

Article

Synthesis of a novel series of amino acid prodrugs based on tegafur and evaluation of their antitumor activity.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 743, doi. 10.5246/jcps.2021.09.062

By:

Shiqi Xu;
Liyan Zhu;
Chao Hao;
Wenqian Liu;
Chenglong Chen;
Yongyi Chen;
Aiqin Liu

Publication type:

Article

Preparation and evaluation of doxorubicin-luminespib co-loaded multivesicular liposomes.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 736, doi. 10.5246/jcps.2021.09.061

By:

Yajie Liu;
Yu Wang;
Jiajia Li;
Xiaoqing Xu;
Xinru Li

Publication type:

Article

Transcriptome-wide identification of differentially expressed genes and long non-coding RNAs in nitroglycerin-tolerant rat aorta.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 725, doi. 10.5246/jcps.2021.09.060

By:

Chunya Cao;
Kai He;
Zhenhua Zeng;
Jianxin Liu;
Wei Cai;
Weihua Wu

Publication type:

Article

(-)-Epicatechin gallate serves as a novel new delhi metallo-β-lactamase-1 (NDM-1) inhibitor.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 716, doi. 10.5246/jcps.2021.09.059

By:

Qian Wang;
Chennan Liu;
Jiangxue Han;
Sihan Liu;
Chunling Xiao;
Yan Guan;
Xinghua Li;
Ying Wang;
Xiao Wang;
Jianzhou Meng;
Maoluo Gan;
Yishuang Liu

Publication type:

Article

Exploring the mechanism of Fu-Zi Decoction in treatment of chronic heart failure based on network pharmacology and molecular docking technology.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 9, p. 705, doi. 10.5246/jcps.2021.09.058

By:

Taixiang Gao;
Feng Zhao;
Liyao Shi;
Rui Wang

Publication type:

Article